Congenital Heart DiseaseNCIt concept

https://sfar.org/anesthesie-pour-chirurgie-non-cardiaque-des-patients-adultes-porteurs-de-cardiopathie-congenitale/
2023
France
practice guideline
No History of Rheumatic Fever
Fluorescence In Situ Hybridization Was Not Performed
Documentation Absent
Evidence of Disease Absent after Completion of Therapy
Anesthesia, Cardiac Procedures
ERBB2 Mutation Analysis Was Not Performed
BRAF Mutation Analysis Was Not Performed
Nitric Oxide Measurement
KRAS Mutation Analysis Was Not Performed
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
Adjuvant I-131 Therapy Negative
ALK Rearrangement Analysis Was Not Performed
Norway
ATRX Mutation Analysis Was Not Performed
NRAS Mutation Analysis Was Not Performed
lack of sensation
ROS1 Rearrangement Analysis Was Not Performed
Local Anesthesia Agents were not Administered
No History of Congenital Heart Disease
EGFR Mutation Analysis Was Not Performed
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
Regional Anesthesia was not Administered
patients
History of Medical Treatment Absent
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
Patient was Not Previously Evaluated for Current Chief Complaint
Physician Diagnosed Diabetes Absent
anesthesia
Congenital Heart Disease
Adjuvant Post-operative Chemotherapy Was Not Administered
PTEN Gene Mutation Negative
PDGFRA Mutation Analysis Was Not Performed
Preoperative IV Sedation was Not Administered
SDH Complex Mutation Analysis Was Not Performed
Therapeutic Ionizing Radiation to Head History Absent
Chief Complaint Not Caused by Trauma
Adjuvant Post-operative Radiation Therapy Was Not Administered
Cardiac Surgery
operative procedure, nos
heart, nos
Negation
Chemotherapy Not Received
Intervention Not Given for Kawasaki Disease
Family History of Stomach Cancer Absent
Preoperative IV Antiemetics were not Administered
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
Any Metastatic Diagnosis Absent
Lymph Node Dissection Was Not Performed
NON Mouse
No History of Non-Cardiac Surgery
Other Preoperative IV Medications were not Administered
adult
BRAF Rearrangement Analysis Was Not Performed
Intercurrent Illness is Absent at Onset of Chief Complaint
Caffeine Not Routinely Consumed
RET Rearrangement Analysis Was Not Performed
Neither
surgery, cardiac
New Tumor Event After Initial Treatment Absent
First Degree Family History Cancer Negative
MET Mutation Analysis Was Not Performed
KIT Mutation Analysis Was Not Performed
Minor Criteria for Rheumatic Heart Disease Not Present
heart disease, nos
No Response to Intervention for Kawasaki Disease
has patient
New Disease is not Multifocal
Additional Surgery for New Metastatic Tumor Event Was Not Performed
NF1 Mutation Analysis Was Not Performed
MGMT Promoter Methylation Testing Was Not Performed
Another Form of Birth Control was not Used
Preoperative IV Opiates were not Administered
Patient was not Postmenopausal with no Prior Oophorectomy
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
Medication Not Taken
ATRX Gene Mutation Negative
Tumor Reoccurrence Absent After Initial Treatment
Nitric Oxide
1p/19q Deletion Analysis Was Not Performed
Has No Sibling
Radiation History Negative
IDH Family Wildtype
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
Routine Cytogenetics Were not Completed
adulthood
First Degree Family History of Primary Brain Tumor Negative
Radiation Therapy Not Received
Additional Immunohistochemistry Was Not Performed
TP53 Mutation Analysis Was Not Performed
No Known History of Alcohol Use
History of Colorectal Cancer Negative
thoracic surgery
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
Paraneoplastic Syndrome is Not Present
Unemployed
Preoperative IV Antacids were not Administered
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Use of Smokeless Tobacco at Time of Diagnosis Negative
Additional Surgery for New Tumor Event Absent
Benzocaine
No History of Myopathy
FBXW4 wt Allele
heart defects, congenital
Chief Complaint was Not Witnessed
No History of Kawasaki Disease
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Neither Case or Control Status
10q23/PTEN Locus Deletion Analysis Was Not Performed
PTEN Mutation Analysis Was Not Performed
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
IV Anesthesia was not Administered
Hypertension Absent
Regular Smokeless Tobacco Use for Six Weeks or More Negative
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
Surgery Patient
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Tumor Progression Absent After Initial Treatment
Not Lost to Follow-Up
Legal Adult
Additional Molecular Studies Were Not Performed
IDH Family Mutation Analysis Was Not Performed
No History of Neonatal Complication
Anesthesia Procedure
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
heart surgery
EGFR Amplification Analysis Was Not Performed
No History of Gestational Complication
First Degree Family History Thyroid Cancer Negative
Chemical/Occupational Exposure Absent
Adjuvant Post-operative Immunological Therapy Was Not Administered
No Known History of Illicit Drug Use
Cancer History Absent
EGFR Gene Amplification Negative

---